
Sunday, February 25, 2024 4:05:42 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent RVMD News
- Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference • GlobeNewswire Inc. • 01/29/2025 09:05:00 PM
- Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 09:05:00 PM
- Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares • GlobeNewswire Inc. • 12/05/2024 09:05:49 PM
- Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 12/04/2024 03:38:42 AM
- Revolution Medicines Announces Commencement of Public Offering of Common Stock • GlobeNewswire Inc. • 12/02/2024 09:31:20 PM
- Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio • GlobeNewswire Inc. • 12/02/2024 12:30:02 PM
- Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024 • GlobeNewswire Inc. • 11/27/2024 09:05:00 PM
- Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress • GlobeNewswire Inc. • 11/06/2024 09:02:32 PM
- Revolution Medicines to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/05/2024 02:00:30 PM
- Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024 • GlobeNewswire Inc. • 10/30/2024 08:05:23 PM
- Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma • GlobeNewswire Inc. • 10/25/2024 08:15:00 AM
- Revolution Medicines Presents Updated Data from RMC-6236 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma • GlobeNewswire Inc. • 10/23/2024 10:00:49 AM
- Revolution Medicines Announces First Patient Dosed in Phase 3 Study Evaluating RMC-6236 in Previously Treated Patients with Metastatic Pancreatic Ductal Adenocarcinoma • GlobeNewswire Inc. • 10/21/2024 08:05:39 PM
- Revolution Medicines to Deliver Multiple Presentations at the 2024 AACR-NCI-EORTC Symposium and Host Investor Webcast • GlobeNewswire Inc. • 10/07/2024 01:00:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 08:15:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 08:14:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:34:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:34:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/07/2024 09:07:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:10:32 PM
- Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress • GlobeNewswire Inc. • 08/07/2024 08:05:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:10 PM
- Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 12:03:35 PM
- Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer • GlobeNewswire Inc. • 07/11/2024 04:00:53 PM
FEATURED Animoca Brands leads Hivello funding round ahead of Token Listing • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM